- Approval Id
- 9b6bd8259d67f26b
- Drug Approval Philippines Name
- Nimenrix
- Product Name
- Nimenrix
- Registration Number
- BR-924
- Brand Name
- Nimenrix
- Generic Name
- Meningococcal Group A, C, W-135 And Y Conjugate
- Dosage Form
- Lyophilized Powder For Solution For Injection (IM)
- Dosage Strength
- Formulation:
After reconstitution, each dose (0.5 mL) contains: Neisseria meningitidis group A polysaccharide* 5 mcg Neisseria meningitidis group C polysaccharide*
5 mcg
Neisseria meningitidis group W-135 polysaccharide* Neisseria meningitidis group Y polysaccharide*
5 mcg
5 mcg
*conjugated to tetanus toxoid carrier protein
44 mcg
- Manufacturer
- Pfizer Manufacturing Belgium NV
- Company Detail Path
- /organization/pfizer-manufacturing-belgium
- Importer Detail Path
- /organization/pfizer-inc-pleasant-prairie-wisconsin-united-states
- Issuance Date
- 28 December 2022
- Expiry Date
- 28 December 2027
- Pharmacologic Category
- Vaccines
- Classification
- Prescription Drug (RX)
